Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00112346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Multicenter Phase II Study of Gemcitabine/Platinum/Cetuximab Versus Gemcitabine/Platinum as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to estimate the number of patients with non-small cell lung cancer whose tumor responds to the treatments given in this study.
Study identification
- NCT ID
- NCT00112346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Dec 2006 (Actual)
- Last update posted
- Oct 28, 2015
2005 – 2006
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Mobile | Alabama | — | — |
| Local Institution | Anchorage | Alaska | — | — |
| Local Institution | Bakersfield | California | — | — |
| Local Institution | Corona | California | — | — |
| Local Institution | Oxnard | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Whittier | California | — | — |
| Local Institution | Lakewood | Colorado | — | — |
| Local Institution | Boynton Beach | Florida | — | — |
| Local Institution | Brooksville | Florida | — | — |
| Local Institution | Inverness | Florida | — | — |
| Local Institution | Pembroke Pines | Florida | — | — |
| Local Institution | Austell | Georgia | — | — |
| Local Institution | Honolulu | Hawaii | — | — |
| Local Institution | Skokie | Illinois | — | — |
| Local Institution | Muncie | Indiana | — | — |
| Local Institution | Annapolis | Maryland | — | — |
| Local Institution | Frederick | Maryland | — | — |
| Local Institution | Rockville | Maryland | — | — |
| Local Institution | Plymouth | Massachusetts | — | — |
| Local Institution | Farmington | New Mexico | — | — |
| Local Institution | Armonk | New York | — | — |
| Local Institution | Stony Brook | New York | — | — |
| Local Institution | Gastonia | North Carolina | — | — |
| Local Institution | Wilmington | North Carolina | — | — |
| Local Institution | Bismarck | North Dakota | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Vancouver | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00112346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2015 · Synced Sep 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00112346 live on ClinicalTrials.gov.